Benzinga | Dec 14, 2020 06:21AM EST

HC Wainwright & Co. Maintains Neutral on Aerpio Pharmaceuticals, Lowers Price Target to $1.5

HC Wainwright & Co. maintains Aerpio Pharmaceuticals (NASDAQ:ARPO) with a Neutral and lowers the price target from $2 to $1.5.